References
- Cornish, W.R. and Llewelyn, D. (2003). Intellectual Property. Sweet & Maxwell.
- Mazzoleni, R. and Nelson, R.R. (1998). The benefits and costs of strong patent protection: a contribution to the current debate. “Research Policy”, 27, 3: 273–284.
- The Nuffield Discussion Paper on The Ethics of Patenting DNA (Http://www.nuffieldbioethics.org). Guidelines for Examination in the European Patent Office, 1999.
- ▪ Plant Genetic Systems/Glutamine Synthetase Inhibitors [1995] EPOR 357
- ▪ Harvanl/Oncomouse [1990] O.J. EPO 476; [1992] O.J. EPO 589.
- ▪ Plant Genetic Systems v Greenpeace (T356/93) [1995] European Patent Office Reports 357.
- ▪ Howard Florey/Relaxin [1995] European Patent Office Reports 541
- The Warnock Report (1984) Report of the Committee of Inquiry into Human Fertilisation and Embryology (Cmnd 9314, 1984).
- The Nuffield Council on Bioethics (2000) Stem Cell Therapy: The Ethical Issues.